Wearable tech could spot Post-Surgery problems early

NCT ID NCT04596384

Ongoing Symptom relief Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether a home-based telemonitoring program, which tracks symptoms and daily steps using a wearable device and app, can improve recovery and reduce complications within 30 days after abdominal surgery for gastrointestinal, genitourinary, or gynecologic cancers. Participants are randomly assigned to either the telemonitoring program or standard surgeon-only care. The study measures changes in daily step count, post-operative complications, and time to hospital readmission to see if early detection of problems can lead to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Home-based telemonitoring program using a wearable activity tracker and symptom reporting app
What this could lead to: If effective, this approach could help doctors detect and treat post-surgery problems early, improving recovery and reducing complications for cancer patients.
What could go wrong: The trial is early and may not show a clear benefit. Patients may find the technology burdensome, and results may not apply to all types of surgery or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGESTIVE SYSTEM CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer digestive system cancer digestive system carcinoma female reproductive organ cancer malignant urinary system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIGESTIVE SYSTEM CARCINOMA GENITOURINARY SYSTEM CARCINOMA MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

City of Hope Antelope Valley

Lancaster, California, 93534, United States
City of Hope Comprehensive Cancer Center

Duarte, California, 91010, United States
City of Hope South Pasadena

South Pasadena, California, 91030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.